Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Randomised-controlled Within-subject Crossover Trial to Determine Levetiracetam Efficacy for Memory Impairment in Parkinson's Disease: A Proof-of-concept Study

NCT04643327 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT04643327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04643327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Randomised-controlled Within-subject Crossover Trial to Determine Levetiracetam Efficacy for Memory Impairment in Parkinson's Disease: A Proof-of-concept Study
Lead sponsor
The University of Queensland
Phase
Phase 2
Overall status
Recruiting
Start date
February 9, 2021
Completion date
December 31, 2025
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

memory impairment, mild cognitive impairment, parkinson disease